Jochen Büchner

  • Senior consultant; PhD
 

Publications 2020

Balduzzi A, Bönig H, Jarisch A, Nava T, Ansari M, Cattoni A, Prunotto G, Lucchini G, Krivan G, Matic T, Kalwak K, Yesilipek A, Ifversen M, Svec P, Buechner J, Vettenranta K, Meisel R, Lawitschka A, Peters C, Gibson B, Dalissier A, Corbacioglu S, Willasch A, Dalle JH, Bader P et al. (2020)
ABO incompatibile graft management in pediatric transplantation
Bone Marrow Transplant
DOI 10.1038/s41409-020-0981-7, PubMed 32594103

Balduzzi A, Bönig H, Jarisch A, Nava T, Ansari M, Cattoni A, Prunotto G, Lucchini G, Krivan G, Matic T, Kalwak K, Yesilipek A, Ifversen M, Svec P, Buechner J, Vettenranta K, Meisel R, Lawitschka A, Peters C, Gibson B, Dalissier A, Corbacioglu S, Willasch A, Dalle JH, Bader P et al. (2020)
Correction: ABO incompatibile graft management in pediatric transplantation
Bone Marrow Transplant (in press)
DOI 10.1038/s41409-020-01012-z, PubMed 32753704

Nava T, Ansari M, Dalle JH, de Heredia CD, Güngör T, Trigoso E, Falkenberg U, Bertaina A, Gibson B, Jarisch A, Balduzzi A, Boenig H, Krivan G, Vettenranta K, Matic T, Buechner J, Kalwak K, Lawitschka A, Yesilipek A, Lucchini G, Peters C, Turkiewicz D, Niinimäki R, Diesch T, Lehrnbecher T et al. (2020)
Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplant, 55 (6), 1126-1136
DOI 10.1038/s41409-020-0818-4, PubMed 32029909

Nava T, Ansari M, Dalle JH, de Heredia CD, Güngör T, Trigoso E, Falkenberg U, Bertaina A, Gibson B, Jarisch A, Balduzzi A, Boenig H, Krivan G, Vettenranta K, Matic T, Buechner J, Kalwak K, Lawitschka A, Yesilipek A, Lucchini G, Peters C, Turkiewicz D, Niinimäki R, Diesch T, Lehrnbecher T et al. (2020)
Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplant, 55 (6), 1214
DOI 10.1038/s41409-020-0838-0, PubMed 32080355

Strand J, Gul KA, Erichsen HC, Lundman E, Berge MC, Trømborg AK, Sørgjerd LK, Ytre-Arne M, Hogner S, Halsne R, Gaup HJ, Osnes LT, Kro GAB, Sorte HS, Mørkrid L, Rowe AD, Tangeraas T, Jørgensen JV, Alme C, Bjørndalen TEH, Rønnestad AE, Lang AM, Rootwelt T, Buechner J, Øverland T et al. (2020)
Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined Immunodeficiency
Front Immunol, 11, 1417
DOI 10.3389/fimmu.2020.01417, PubMed 32754152

Willasch AM, Peters C, Sedláček P, Dalle JH, Kitra-Roussou V, Yesilipek A, Wachowiak J, Lankester A, Prete A, Hamidieh AA, Ifversen M, Buechner J, Kriván G, Hamladji RM, Diaz-de-Heredia C, Skorobogatova E, Michel G, Locatelli F, Bertaina A, Veys P, Dupont S, Or R, Güngör T, Aleinikova O, Sufliarska S et al. (2020)
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study
Bone Marrow Transplant, 55 (8), 1540-1551
DOI 10.1038/s41409-020-0854-0, PubMed 32203263

Publications 2019

Bonig H, Kuçi Z, Kuçi S, Bakhtiar S, Basu O, Bug G, Dennis M, Greil J, Barta A, Kállay KM, Lang P, Lucchini G, Pol R, Schulz A, Sykora KW, Teichert von Luettichau I, Herter-Sprie G, Ashab Uddin M, Jenkin P, Alsultan A, Buechner J, Stein J, Kelemen A, Jarisch A, Soerensen J et al. (2019)
Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients
Cells, 8 (12)
DOI 10.3390/cells8121577, PubMed 31817480

Ifversen M, Turkiewicz D, Marquart HV, Winiarski J, Buechner J, Mellgren K, Arvidson J, Rascon J, Körgvee LT, Madsen HO, Abrahamsson J, Lund B, Jonsson OG, Heilmann C, Heyman M, Schmiegelow K, Vettenranta K (2019)
Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience
Br J Haematol, 184 (6), 982-993
DOI 10.1111/bjh.15761, PubMed 30680711

Laetsch TW, Myers GD, Baruchel A, Dietz AC, Pulsipher MA, Bittencourt H, Buechner J, De Moerloose B, Davis KL, Nemecek E, Driscoll T, Mechinaud F, Boissel N, Rives S, Bader P, Peters C, Sabnis HS, Grupp SA, Yanik GA, Hiramatsu H, Stefanski HE, Rasouliyan L, Yi L, Shah S, Zhang J et al. (2019)
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial
Lancet Oncol, 20 (12), 1710-1718
DOI 10.1016/S1470-2045(19)30493-0, PubMed 31606419

Pearson ADJ, Scobie N, Norga K, Ligas F, Chiodin D, Burke A, Minard-Colin V, Adamson P, Marshall LV, Balakumaran A, Benettaib B, Bhargava P, Bollard CM, Bolotin E, Bomken S, Buechner J, Burkhardt B, Caron H, Copland C, Demolis P, Egorov A, Farhan M, Zugmaier G, Gross T, Horton-Taylor D et al. (2019)
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children
Eur J Cancer, 110, 74-85
DOI 10.1016/j.ejca.2019.01.013, PubMed 30772656

Søraas A, Matsuyama M, de Lima M, Wald D, Buechner J, Gedde-Dahl T, Søraas CL, Chen B, Ferrucci L, Dahl JA, Horvath S, Matsuyama S (2019)
Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cells
Aging Cell, 18 (2), e12897
DOI 10.1111/acel.12897, PubMed 30712319

Publications 2018

Bader P, Kuçi Z, Bakhtiar S, Basu O, Bug G, Dennis M, Greil J, Barta A, Kállay KM, Lang P, Lucchini G, Pol R, Schulz A, Sykora KW, von Luettichau I, Herter-Sprie G, Uddin MA, Jenkin P, Alsultan A, Buechner J, Stein J, Kelemen A, Jarisch A, Soerensen J, Salzmann-Manrique E et al. (2018)
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)
Bone Marrow Transplant, 53 (7), 852-862
DOI 10.1038/s41409-018-0102-z, PubMed 29379171

Buechner J, Kersten MJ, Fuchs M, Salmon F, Jäger U (2018)
Chimeric Antigen Receptor-T Cell Therapy: Practical Considerations for Implementation in Europe
Hemasphere, 2 (1), e18
DOI 10.1097/HS9.0000000000000018, PubMed 31723747

Diep PP, Melberg HO, Brinch L, Buechner J, Fløisand Y, Gedde-Dahl T, Loge JH, Tjønnfjord GE, Ruud E (2018)
Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway
Bone Marrow Transplant, 53 (5), 657-660
DOI 10.1038/s41409-018-0091-y, PubMed 29358600

Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH et al. (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
N Engl J Med, 378 (5), 439-448
DOI 10.1056/NEJMoa1709866, PubMed 29385370

Orlando EJ, Han X, Tribouley C, Wood PA, Leary RJ, Riester M, Levine JE, Qayed M, Grupp SA, Boyer M, De Moerloose B, Nemecek ER, Bittencourt H, Hiramatsu H, Buechner J, Davies SM, Verneris MR, Nguyen K, Brogdon JL, Bitter H, Morrissey M, Pierog P, Pantano S, Engelman JA, Winckler W (2018)
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
Nat Med, 24 (10), 1504-1506
DOI 10.1038/s41591-018-0146-z, PubMed 30275569

Publications 2017

Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, Booth C, Buechner J, Buckley RH, Ouachée-Chardin M, Deripapa E, Drabko K, Eapen M, Feuchtinger T, Finocchi A, Gaspar HB, Ghosh S, Gillio A, Gonzalez-Granado LI, Grunebaum E, Güngör T, Heilmann C, Helminen M, Higuchi K, Imai K et al. (2017)
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders
J Allergy Clin Immunol, 141 (1), 322-328.e10
DOI 10.1016/j.jaci.2017.02.036, PubMed 28392333

Publications 2016

Bartelheim K, Nemes K, Seeringer A, Kerl K, Buechner J, Boos J, Graf N, Dürken M, Gerss J, Hasselblatt M, Kortmann RD, Teichert von Luettichau I, Nagel I, Nygaard R, Oyen F, Quiroga E, Schlegel PG, Schmid I, Schneppenheim R, Siebert R, Solano-Paez P, Timmermann B, Warmuth-Metz M, Frühwald MC (2016)
Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007
Cancer Med, 5 (8), 1765-75
DOI 10.1002/cam4.741, PubMed 27228363

Publications 2013

Panagopoulos I, Micci F, Thorsen J, Haugom L, Buechner J, Kerndrup G, Tierens A, Zeller B, Heim S (2013)
Fusion of ZMYND8 and RELA genes in acute erythroid leukemia
PLoS One, 8 (5), e63663
DOI 10.1371/journal.pone.0063663, PubMed 23667654

Publications 2012

Buechner J, Einvik C (2012)
N-myc and noncoding RNAs in neuroblastoma
Mol Cancer Res, 10 (10), 1243-53
DOI 10.1158/1541-7786.MCR-12-0244, PubMed 22936790

Publications 2011

Haug BH, Henriksen JR, Buechner J, Geerts D, Tømte E, Kogner P, Martinsson T, Flægstad T, Sveinbjørnsson B, Einvik C (2011)
MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma
Carcinogenesis, 32 (7), 1005-12
DOI 10.1093/carcin/bgr073, PubMed 21572098

Henriksen JR, Buechner J, Løkke C, Flægstad T, Einvik C (2011)
Inhibition of gene function in mammalian cells using short-hairpin RNA (shRNA)
Methods Mol Biol, 703, 189-204
DOI 10.1007/978-1-59745-248-9_13, PubMed 21125491

Henriksen JR, Haug BH, Buechner J, Tømte E, Løkke C, Flaegstad T, Einvik C (2011)
Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma
BMC Dev Biol, 11, 1
DOI 10.1186/1471-213X-11-1, PubMed 21194500

Publications 2010

Buechner J, Henriksen JR, Haug BH, Tømte E, Flaegstad T, Einvik C (2010)
Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells
Differentiation, 81 (1), 25-34
DOI 10.1016/j.diff.2010.09.184, PubMed 20980091

Kranendijk M, Struys EA, Gibson KM, Wickenhagen WV, Abdenur JE, Buechner J, Christensen E, de Kremer RD, Errami A, Gissen P, Gradowska W, Hobson E, Islam L, Korman SH, Kurczynski T, Maranda B, Meli C, Rizzo C, Sansaricq C, Trefz FK, Webster R, Jakobs C, Salomons GS (2010)
Evidence for genetic heterogeneity in D-2-hydroxyglutaric aciduria
Hum Mutat, 31 (3), 279-83
DOI 10.1002/humu.21186, PubMed 20020533

Publications 2009

Berg T, Kalsaas AH, Buechner J, Busund LT (2009)
Ewing sarcoma-peripheral neuroectodermal tumor of the kidney with a FUS-ERG fusion transcript
Cancer Genet Cytogenet, 194 (1), 53-7
DOI 10.1016/j.cancergencyto.2009.06.002, PubMed 19737655

Publications 2003

Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hählen K, Hasle H, Licht JD, Gelb BD (2003)
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
Nat Genet, 34 (2), 148-50
DOI 10.1038/ng1156, PubMed 12717436

Page visits: 28